Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2025-12-24 @ 6:39 PM
NCT ID:
NCT04054557
Eligibility Criteria:
Inclusion Criteria:
* • Signed informed consent obtained prior to any study specific assessments and procedures
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2
* Women or men diagnosed with stage 0-III hormone receptor positive (estrogen receptor positive \[ER\] and /or progesterone receptor \[PR\] positive) breast cancer
\* Staging for eligibility should utilize the most recent American Joint Committee on Cancer (AJCC) breast cancer staging version
* Patients (Pts) must have undergone breast surgery for their diagnosis of breast cancer
* Adjuvant endocrine therapy has been prescribed by their treating physician
\* Patients may receive concurrent adjuvant radiation therapy plus endocrine therapy in the post-operative setting
* Have a cell phone with text messaging ability
* Have access to a computer, tablet, or smart phone to complete electronic surveys
* Patient must be willing to setup an online Jefferson MyChart account
* Patients who have been on endocrine therapy for more than 4 years
Exclusion Criteria:
* Pts with stage IV metastatic breast cancer
* Patients unable to participate in patient portal communication (e.g. do not have either a smart phone, laptop, access to a computer and/ or access to a device with a webcam)
* Pts who are non-English speaking and English illiterate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04054557
Study Brief:
Protocol Section:
NCT04054557